About Defined Bioscience
Defined Bioscience is a Healthcare company based in San Diego (United States) founded in 2020 by Steven Rees. Developer of cell culture reagents, growth medium, and kits for cell-based assays. The company has 6 employees. Its chief executive, as recorded, is Steven Rees. Defined Bioscience offers products and services including HiDef-B8, FGF2-G3, FGF2 (chicken), FGF2 (tuna), and HiDef PBS/EDTA. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Cell Culture. Its legal entity is DEFINED BIOSCIENCE, INC. Its competitors include BioLife Solutions, RoosterBio and ArunA Bio; 2 of its 3 listed competitors have raised funding.
Company details
Defined Bioscience was founded in 2020 and is based in San Diego, United States. Operations focus on the biotechnology sector, where cell culture reagents, growth media, and kits for cell-based assays are developed. A key product, the HiDef-B8 stem cell medium supplement, is formulated for culturing hiPSCs, iPSC-derived cells, and organoids. These offerings support research in stem cell and organoid technologies.
- Headquarters San Diego, United States
- Employees 6
- Founders Steven Rees
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website definedbioscience.com
- Social LinkedIn X
- Legal Name Defined Bioscience, Inc.
- Latest Funding Round$275K (USD), Grant
Jul 2024
- Investors
- Employee Count6
Products & Services of Defined Bioscience
Defined Bioscience offers a comprehensive portfolio of products and services, including HiDef-B8, FGF2-G3, FGF2 (chicken), FGF2 (tuna), and HiDef PBS/EDTA.
Animal-free medium for optimized stem cell culture
Growth factor for cell culture applications
Specific growth factor variant for research use
Alternative growth factor for cell culture
Reagent for cell culture maintenance
Tailored media for specific research needs
Funding Insights of Defined Bioscience
- Total Rounds 2
- Last Round Grant — $274,995
- First Round $1.5M
(May 2021)
- Investors Count 1
All 2 funding rounds of Defined Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Defined Bioscience
Defined Bioscience has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Defined Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Defined Bioscience
1 people are tracked at Defined Bioscience (1 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Steven Rees | Founder & CEO | Leadership |
Complete people profiles for Defined Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Defined Bioscience
3 dated milestones of Defined Bioscience across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Defined Bioscience is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Grant, of $275K.
Competitors of Defined Bioscience
Defined Bioscience has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and ArunA Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biolifesolutions.com | 1987 | Bothell, United States | 685 | Tissue hypothermic storage and cryopreservation freeze media are developed. | ||
| roosterbio.com | 2012 | Frederick, United States | $38.41M | 69 | Developer of human mesenchymal stem cells and extracellular vesicles | |
| arunabio.com | 2017 | Athens, United States | $38.51M | Neural exosome platform is developed for neurodegenerative disease therapeutics. |
Detailed competitors of Defined Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Defined Bioscience
The website of Defined Bioscience (definedbioscience.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 42.1% vs previous month
Websites whose visitors overlap most with Defined Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rosalind.bio | 100% | 9.1K | #2,228,840 | View details | |
| empiri.co | 100% | 2.5K | #7,036,136 | View details | |
invivoscribe.com | invivoscribe.com | 99% | #2,713,213 | – | |
biopioneerinc.com | biopioneerinc.com | 98% | #5,300,424 | – | |
| abterrabio.com | 96% | 2.3K | #7,094,620 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Defined Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Defined Bioscience (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Defined Bioscience
Defined Bioscience was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Defined Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Steven Rees is the CEO of Defined Bioscience, as recorded in our data. They have also founded this company.
Defined Bioscience has 6 employees.
Defined Bioscience was founded in 2020 and is based in San Diego, United States. Operations focus on the biotechnology sector, where cell culture reagents, growth media, and kits for cell-based assays are developed. A key product, the HiDef-B8 stem cell medium supplement, is formulated for culturing hiPSCs, iPSC-derived cells, and organoids. These offerings support research in stem cell and organoid technologies.
Defined Bioscience's top competitors include RoosterBio, BioLife Solutions and ArunA Bio.
Defined Bioscience offers HiDef-B8, FGF2-G3, FGF2 (chicken), FGF2 (tuna), and 2 more products and services.
Defined Bioscience has 1 investor. Key investors include HHS.
Defined Bioscience operates through Defined Bioscience, Inc..